395 related articles for article (PubMed ID: 16510488)
1. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Lamers CT; Bechara A; Rizzo M; Ramaekers JG
J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
[TBL] [Abstract][Full Text] [Related]
2. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
[TBL] [Abstract][Full Text] [Related]
5. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
6. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
7. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
8. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
9. Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine.
Kuypers KP; Ramaekers JG
J Psychopharmacol; 2005 Nov; 19(6):633-9. PubMed ID: 16272186
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
12. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
13. Mental disorders in current and former heavy ecstasy (MDMA) users.
Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
[TBL] [Abstract][Full Text] [Related]
14. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
15. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
Halpern JH; Pope HG; Sherwood AR; Barry S; Hudson JI; Yurgelun-Todd D
Drug Alcohol Depend; 2004 Aug; 75(2):135-47. PubMed ID: 15276218
[TBL] [Abstract][Full Text] [Related]
16. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
17. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
Huxster JK; Pirona A; Morgan MJ
J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
[TBL] [Abstract][Full Text] [Related]
18. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
Golding JF; Groome DH; Rycroft N; Denton Z
Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
